Overview

Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema

Status:
Completed
Trial end date:
2012-04-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and efficacy of alitretinoin in the treatment of severe chronic hand eczema that does not respond to treatment with potent topical steroids.
Phase:
Phase 3
Details
Lead Sponsor:
Stiefel, a GSK Company
Collaborator:
Basilea Pharmaceutica
Treatments:
Alitretinoin
Tretinoin